Author

Girijesh Kumar Patel

SGPGIMS, TTUHSC, MCI-USA, GEU, IITR - Cited by 1,583 - Cancer Pathobiology - Drug Resistance - Stemness - Exosomes-Biomarker - Multiomics platforms

Biography

Girijesh Kumar Patel is currently working in Department of Oncologic Sciences, Mitchell Cancer Institute, University of South Alabama, Mobile, Alabama, USA. His international experience includes various programs, contributions and participation in different countries for diverse fields of study.  His research interests reflect in his wide range of publications in various national and international journals.  
Title
Cited by
Year
Comparative analysis of exosome isolation methods using culture supernatant for optimum yield, purity and downstream applications
GK Patel, MA Khan, H Zubair, SK Srivastava, M Khusman, S Singh, ...Scientific Reports 9 (1), 5335, 2019201
414
2019
Cancer Chemoprevention by Phytochemicals: Nature’s Healing Touch
H Zubair, S Azim, A Ahmad, MA Khan, GK Patel, S Singh, AP SinghMolecules 22 (3), 395, 2017201
105
2017
Drug-loaded exosomal preparations from different cell types exhibit distinctive loading capability, yield, and antitumor efficacies: a comparative analysis
R Kanchanapally, SK Deshmukh, SK Srivastava, GK Patel, AP Singh, ...International Journal of Nanomedicine 14, 531-541, 2019201
91
2019
Neuroendocrine Differentiation of Prostate Cancer- An Intriguing Example of Tumor Evolution at Play
GK Patel, N Chugh, M TripathiCancers 11, 1405; doi:10.3390/cancers11101405, 2019201
75
2019
Molecular drivers of pancreatic cancer pathogenesis: looking inward to move forward
MA Khan, S Azim, H Zubair, A Bhardwaj, GK Patel, M Khushman, S Singh, ...International Journal of Molecular Sciences 18, 779-802, 2017201
73
2017
Exosomal Markers (CD63 and CD9) Expression Pattern Using Immunohistochemistry in Resected Malignant and Nonmalignant Pancreatic Specimens
M Khushman, A Bhardwaj, GK Patel, JA Laurini, K Roveda, M Tan, ...Pancreas 46 (6), 782-88 DOI:10.1097/MPA.0000000000000847, 2017201
72
2017
Hydroxytyrosol induces apoptosis and cell cycle arrest and suppresses multiple oncogenic signaling pathways in prostate cancer cells
H Zubair, A Bhardwaj, A Ahmad, SK Srivastava, MA Khan, GK Patel, ...Nutrition and cancer 69 (6), 932-942, 2017201
63
2017
Racial health disparities in ovarian cancer: not just black and white
SK Srivastava, A Ahmad, O Miree, GK Patel, S Singh, R Rocconi, ...Journal of Ovarian Research 58 (10(1)), 1-9, 2017201
37
2017
Co-targeting of CXCR4 and hedgehog pathways disrupts tumor-stromal crosstalk and improves chemotherapeutic efficacy in pancreatic cancer
MA Khan, SK Srivastava, H Zubair, GK Patel, S Arora, JE Carter, ...Journal of Biological Chemistry 295, 8413-8424., 2020202
30
2020
Germline pharmacogenomics of DPYD*9A (c.85T>C) variant in patients with gastrointestinal malignancies treated with fluoropyrimidines
M Khushman, GK Patel, PJ Hosein, JA Laurini, D Cameron, DR Clarkson, ...Journal of Gastrointestinal Oncology 9 (3), 416-4124, 2018201
23
2018
Exosomal markers (CD63 and CD9) expression and their prognostic significance using immunohistochemistry in patients with pancreatic ductal adenocarcinoma
M Khushman, GK Patel, JA Laurini, A Bhardwaj, K Roveda, R Donnell, ...Journal of Gastrointestinal Oncology 10 (4), 695-670, 2019201
18
2019
Helicobacter pylori-Induced Inflammation: Possible Factors Modulating the Risk of Gastric Cancer
S Kumar, GK Patel, UC GhosalPathogens 10 (9), 1099 https://doi.org/10.3390/pathogens10, 2021202
17
2021
Evaluation of genetic diversity among Russet potato clones and varieties from breeding programs across the United States
S Bali, G Patel, R Novy, K Vining, C Brown, D Holm, G Porter, J Endelman, ...PloS One 13 (8), e0201415, 2018201
16
2018
The prevalence of DPYD* 9A (c. 85T> C) genotype and the genotype-phenotype correlation in patients with gastrointestinal malignancies treated with fluoropyrimidines: updated …
AS Maharjan, GA McMillin, GK Patel, S Awan, WR Taylor, S Pai, ...Clinical colorectal cancer 18 (3), e280-e286, 2019201
13
2019
MYB interacts with androgen receptor, sustains its ligand-independent activation and promotes castration resistance in prostate cancer
SK Srivastava, MA Khan, S Anand, H Zubair, SK Deshmukh, GK Patel, ...British Journal of Cancer 126, 1205–1214, 2022202
9
2022
Proteomic analysis of MYB-regulated secretome identifies functional pathways and biomarkers: potential pathobiological and clinical implications
H Zubair*, GK Patel*, MA Khan, A Shafquat, A, Zubair, S Singh, ...Journal of Proteome Research DOI: 10.1021/acs.jproteome.b00641, 2020202
9
2020
Looking at cancer health disparities without the colored lenses
MA Khan, GK Patel, SK Srivastava, JE Carter, JY Pierce, RP Rocconi, ...Cancer health disparities; DOI: 10.9777/chd.2019.1004; PMID: 31440743 3, e1, 20120
8
2018
Molecular cloning, characterization and in silico analysis of a thermostable β-glucosidase enzyme from Putranjiva roxburghii with a significant activity for cellobiose.
B Kar, P Verma, GK Patel, AK SharmaPhytochemistry 140, 151-165, 20120
7
2017
Exosomes: Key Supporters of Tumor Metastasis
GK Patel, H Zubair, MA Khan, SK Srivastava, A Ahmad, MC Patton, ...Exosomes in cancer: diagnostic, pharmaceutical, and therapeutic applications …, 2018201
6
2018
Epidermal growth factor receptor-activating mutation (E746_T751> VP) in pancreatic ductal adenocarcinoma responds to erlotinib, followed by epidermal growth factor receptor …
Epidermal growth factor receptor-activating mutation (E746_T71> VP) in pancreatic ductal adenocarcinoma responds to erlotinib, followed by epidermal growth factor receptor …GK Patel, JB Perry, O Abdul-Rahim, AE Frankel, D Cameron, W Taylor, ...Journal of Cancer Research and Therapeutics 16 (4), 90, 2020202
5
2020

Referred From: https://scholar.google.co.in/citations?user=pi25LnIAAAAJ&hl=en

Cited by
Citations 1583
h-index 17
i10-index 22
Recommended Journals
Open Access Journals